latest news releases from the newsroom
NEW NOMINATION COMMITTEE AT BILIA
In accordance with the instructions approved at the AGM, the following people
have been appointed as members of Bilia’s nomination committee:
Mikael Nordberg, Firstnordic Fonder AB
Per-Erik Molin, SEB Fonder
Hans Hedström, HQ Fonder
Stefan Dahlbo Investment AB Öresund
Mats Qviberg, styrelseordförande i Bilia AB
Shareholders of Bilia are welcome to give suggestions and standpoints to the
Göteborg, 19 October 2005
Bilia AB (publ)
GB&T Bancshares, Inc.
GB&T Bancshares Reports 62.6 Percent Increase in Third Quarter Net Income
GAINESVILLE, Ga., Oct. 19, 2005 (PRIMEZONE) -- GB&T Bancshares, Inc. (Nasdaq:GBTB), a multi-bank holding company with six community banks in markets surrounding Atlanta, Georgia, reported third quarter 2005 net income of $3.9 million compared with $2.4 million for the third quarter of 2004, an increase of 62.6 percent. Over the last twelve months, loans and deposits increased 33.6 percent and 31.1 percent, respectively, generating recurring revenue growth of 32.0 percent for the current quarter compared to the third quarter of 2004.
Pharming Group N.V.
Pharming Presents Human Lactoferrin Results at International Conference
LEIDEN, Netherlands, Oct. 19, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today results from three studies which demonstrate that human lactoferrin produced by Pharming (rhLF) can be considered safe for use in functional foods. Dr. Bertjan Ziere, Senior Director at Pharming, presented the results at the VII International Conference on Lactoferrin (October 16-19, 2005) in Honolulu, Hawaii.